Denali Therapeutics(DNLI.US) Director Sells US$30,471.14 in Common Stock

$Denali Therapeutics(DNLI.US)$ Director SATO VICKI L sold 1,666 shares of common stock on Apr 15, 2024 at an average price of $18.29 for a total value of $30,471.14.Source: Announcement What is statem

moomoo NewsApr 17 17:54 ET

Denali Therapeutics Inc.'s (NASDAQ:DNLI) Low P/S No Reason For Excitement

Denali Therapeutics Inc.'s (NASDAQ:DNLI) price-to-sales (or "P/S") ratio of 7.9x might make it look like a buy right now compared to the Biotechs industry in the United States, where around half of th

Simply Wall StApr 15 06:48 ET

GLP-1s Benefit Parkinson's: Barclays Sees Implications Across Biopharma

Seeking AlphaApr 12 12:02 ET

Denali Therapeutics Is Maintained at Buy by UBS

Denali Therapeutics Is Maintained at Buy by UBS

Dow JonesApr 9 12:15 ET

Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing

Steve E. Krognes, Director, on April 01, 2024, sold 92,500 shares in Denali Therapeutics (DNLI) for $1,896,250. Following the Form 4 filing with the SEC, Krognes has control over a total of 897,341 sh

MT NewswiresApr 3 09:16 ET

Denali Therapeutics(DNLI.US) Director Sells US$1.9 Million in Common Stock

$Denali Therapeutics(DNLI.US)$ Director Krognes Steve E. sold 92,500 shares of Common Stock on Apr 1, 2024 at an average price of $20.5 for a total value of $1.9 million.Source: Announcement What is s

moomoo NewsApr 2 18:49 ET